Versant Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.31K Hold
185
﹤0.01% 2420
2026
Q1
$3.46K Buy
185
+143
+340% +$2.73K ﹤0.01% 2466
2025
Q4
$970 Hold
42
﹤0.01% 2536
2025
Q3
$1.13K Hold
42
﹤0.01% 2490
2025
Q2
$705 Sell
42
-498
-92% -$8.78K ﹤0.01% 2523
2025
Q1
$9.52K Buy
+540
New +$10.8K ﹤0.01% 1744
2024
Q4
Sell
-48
Closed -$1.78K 2420
2024
Q3
$1.78K Hold
48
﹤0.01% 1595
2024
Q2
$2.29K Hold
48
﹤0.01% 1472
2024
Q1
$1.84K Buy
+48
New +$1.56K ﹤0.01% 1381
2023
Q4
Sell
-282
Closed -$11.3K 2009
2023
Q3
$11.3K Buy
+282
New +$13.2K ﹤0.01% 689
2020
Q1
Sell
-23
Closed 1642
2019
Q4
$0 Hold
23
﹤0.01% 1560
2019
Q3
$0 Buy
+23
New +$699 ﹤0.01% 1571

Other funds holding STAA

Versant Capital Management's STAA Position: Q2 2026 in Review

Versant Capital Management held its STAAR Surgical (STAA) position steady in Q2 2026 at 185 shares worth $5.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Versant Capital Management first reported a position in STAA in Q3 2019 and has held it in 12 quarters since. The position peaked at $11.3K in Q3 2023. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Versant Capital Management held 185 shares of STAAR Surgical worth $5.31K as of Q2 2026.
  • Versant Capital Management left its STAAR Surgical share count unchanged in Q2 2026.
  • STAAR Surgical made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2420 holding.
  • Versant Capital Management first reported a position in STAAR Surgical in Q3 2019 and has held it in 12 quarters since.
  • Versant Capital Management's STAAR Surgical position peaked at $11.3K in Q3 2023.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.